Fundz

RenovaroCube completes acquisition of Cyclomics to advance cutting-edge cancer diagnostics

PRIVATEApr 24, 2024

Acquiring Company

Renovaro

Acquired Company

Cyclomics

AmsterdamUtrechtBiotechnologyHealth CareArtificial IntelligenceMedicalMachine LearningHealth DiagnosticsGenetics

Description

Renovaro Inc. (Nasdaq: RENB) has signed an agreement to acquire 100% ownership of Cyclomics, reinforcing their cutting-edge cancer diagnostics partnership. The acquisition reflects a shared commitment by Renovaro Inc. and Cyclomics to advancing state-of-the-art technologies in cancer diagnostics and treatment, positioning RenovaroCube to be a leader in early cancer diagnostics and monitoring of treatment efficacy.

Company Information

Company

Renovaro

Location

Amsterdam, North Holland, Netherlands

About

Renovaro Inc. is a trailblazer in AI-driven early cancer diagnostics and therapeutics. The company aims to accelerate precision and personalized medicine for longevity, powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. RenovaroCube, as a molecular data science company, has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments.

Fundz sees it the moment Renovaro makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Lester
Likely contact at this company
••••••••@••••••••

See Lester's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Renovaro's next move

Learn about Strategic plan

Frequently asked

Who acquired Cyclomics?

Cyclomics was acquired by Renovaro, based in Amsterdam. The deal was reported on April 24, 2024. Renovaro Inc. is a trailblazer in AI-driven early cancer diagnostics and therapeutics. Renovaro is privately held and operates in Biotechnology.

When did Renovaro acquire Cyclomics?

Renovaro's acquisition of Cyclomics was reported on April 24, 2024. Renovaro Inc. (Nasdaq: RENB) has signed an agreement to acquire 100% ownership of Cyclomics, reinforcing their cutting-edge cancer diagnostics partnership. The acquisition reflects a shared commitment by Renovaro Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Cyclomics do?

Cyclomics is a leader in ultra-sensitive 4th generation multi-omics molecular biology. It is privately held, operating in Genetics, and is based in Utrecht.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.